Journal
EXPERT REVIEW OF RESPIRATORY MEDICINE
Volume 16, Issue 9, Pages 983-995Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/17476348.2022.2128770
Keywords
COVID-19; interstitial lung disease; pulmonary fibrosis; long COVID; post-COVID ILD
Categories
Ask authors/readers for more resources
This article discusses the management of post-COVID ILD and highlights the importance of establishing dedicated facilities for the care of these patients. It summarizes the relevant literature regarding the epidemiology, pathophysiology, diagnosis, and treatment of post-COVID ILD. The article discusses pharmacologic and non-pharmacologic options for management. Further research into the pathophysiology and management of post-COVID ILD will improve our understanding of this condition.
Introduction As millions of people worldwide recover from COVID-19, a substantial proportion continue to have persistent symptoms, pulmonary function abnormalities, and radiological findings suggestive of post-COVID interstitial lung disease (ILD). To date, there is limited scientific evidence on the management of post-COVID ILD, necessitating a consensus-based approach. Areas covered A panel of experts in pulmonology and thoracic radiology was constituted. Key questions regarding the management of post-COVID ILD were identified. A search was performed on PubMed and EMBASE and updated till 1 March 2022. The relevant literature regarding the epidemiology, pathophysiology, diagnosis and treatment of post-COVID ILD was summarized. Subsequently, suggestions regarding the management of these patients were framed, and a consensus was obtained using the Delphi approach. Those suggestions which were approved by over 80% of the panelists were accepted. The final document was approved by all panel members. Expert opinion Dedicated facilities should be established for the care of patients with post-COVID ILD. Symptom screening, pulmonary function testing, and thoracic imaging have a role in the diagnosis. The pharmacologic and non-pharmacologic options for the management of post-COVID ILD are discussed. Further research into the pathophysiology and management of post-COVID ILD will improve our understanding of this condition.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available